Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. - Wikidata - awgldk - TriplyDB

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction.

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction.

http://www.wikidata.org/entity/Q34241307

about

Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitor Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance.Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection.Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice A2B adenosine receptor blockade inhibits growth of prostate cancer cells.Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.Roles of sildenafil in enhancing drug sensitivity in cancer.Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation.PDE5 inhibitors enhance celecoxib killing in multiple tumor types.Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice.PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines.PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter Sildenafil stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells via distinct signaling pathways Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligases Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95 Nexavar/Stivarga and viagra interact to kill tumor cells.Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants.Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis.A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells.Possibilities to increase the effectiveness of doxorubicin in cancer cells killing.PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib].Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells.Co-delivery of Sildenafil (Viagra(®)) and Crizotinib for synergistic and improved anti-tumoral therapy.Gambogic acid sensitizes ovarian cancer cells to doxorubicin through ROS-mediated apoptosis.Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer.The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G Iα Oxidation.Molecular mechanisms of pharmaceutical drug binding into calsequestrin.PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide

P2860

Q28534483-DBC1B58A-3D7F-4808-AEF1-9E020D311BF2 Q33727633-FC8762C9-9429-43CC-AF1A-B065D631E92E Q33727865-D8CB3FBA-C518-4046-8323-764479874300 Q34258440-189017B8-443F-48A7-BE67-9A545949405A Q34262532-F6387365-D70F-405F-B8B6-6D30A4425DE0 Q34277031-9F50F973-BFFF-4C64-AB3E-899A30AC63D7 Q34289307-AC5010CF-5D65-4A1E-9E55-8C23E39C5E43 Q34292101-C12B2BFE-D7CA-43BC-9F61-FFC3F47A3001 Q34428464-8A163599-49B6-4239-BBCF-C9CA24D93E54 Q34546999-2F645552-3480-4E51-9074-D1B9C438F33C Q34803651-152E2D9E-EFBF-4D61-B30C-6A18E3CAAE32 Q35022148-2616E69A-BE5B-4638-8C2A-CD934F19D96B Q35228139-D7DFAD24-4AAF-44B1-9E73-957D7ECB0D09 Q35430943-A346A640-7A3F-4C18-BE3C-4D0D1224526D Q35543525-13C6B1F3-3EC7-4BEA-8317-916BAB08EDF8 Q35827798-F4C4B2ED-6F39-4231-9368-5EA73EDC37F3 Q36109004-01562ADD-AE2C-4FF6-AB69-6B2862F7B7C1 Q36124056-50E322E9-D4FD-4DF6-BC4C-29C2BD99A89C Q36366419-83AE1DD8-F20E-40B4-9176-38EB27FE46C7 Q36420145-CE8E8FF3-DEFB-40AC-9298-4CD573BEA631 Q36772298-C11CBD34-D9B6-4E72-B121-9D131C6FEA30 Q36782452-6138E60E-B43C-49F5-A503-A98A055D9882 Q36808335-6BDD1A41-353A-4A2E-9546-C90D9A0889E2 Q36952021-F8DA8D67-1149-4688-A9F5-A51F7E1BC785 Q37142629-5397F46D-ECC6-4A6A-ACD2-505E9C59EB38 Q37153655-2F8B2F9B-3BD7-4FBB-81F2-6790AA78F88C Q37163899-5C895825-4188-4C44-8574-83F8A541F82D Q37219900-AC27307C-BD73-4198-B10D-A2D6864410B7 Q37426831-0D138AB8-0585-4712-98CB-6D4888C406BC Q37603936-A9EABA40-04EF-4246-850F-DD6D4809CC27 Q37937579-F4F50604-2342-440D-AD50-E86A13AFD384 Q38721255-F7F51027-853D-4F7D-9B15-1D3D459CDF69 Q38749854-A30D909D-F8AD-49D3-8440-67092841E3F0 Q39016059-CE9F9510-B422-464C-9C0A-2C55E38DF5DB Q39189439-F3E0A843-280F-40E3-93C1-4BB76444CE1F Q39387219-67082AA3-0E76-4148-B034-E3B6BF5119D9 Q41036693-2ABF10BA-A7E4-42B5-B90A-6161F24E4533 Q41045943-55394BDA-9BE8-4455-830E-113F03A25A54 Q42277029-98023544-0788-4390-8F89-DF7D41ECB3E6 Q42316209-3BDFADCD-C9C1-4147-8ABF-A87384880854

P2860

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction.

http://www.wikidata.org/entity/Q34241307

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@ast

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@en

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@nl

type

label

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@ast

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@en

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@nl

prefLabel

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@ast

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@en

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@nl

P1433

Q34241307-95D2FA66-7BB0-49A1-BE73-F24D967ED0BF

P1476

Q34241307-4DFF230E-6942-4226-9F3C-3812D855814D

P2093

Q34241307-0E773255-B800-4328-92F6-B1C4C74E2D22

Q34241307-147B4858-AD27-494E-8EC7-EEBD7ED5552C

Q34241307-48CDD119-F8E3-41ED-8E22-33FE86C627F5

Q34241307-498D5EBA-ECAE-4EF6-94BD-780E2ED1F73A

Q34241307-4BF60D98-BD58-45A2-9AFA-CC7AFF670502

Q34241307-513EC977-C880-4B95-B869-10F0C100EF13

Q34241307-5893F378-905C-4819-BF2F-7FCE5E20C7D3

Q34241307-5EFBC534-4B06-40AD-AA12-45E68EEBD46C

Q34241307-7071C7CB-835E-4CE0-B507-E8E14BC98983

Q34241307-B316DA39-F7F6-4272-9643-0CA273C528AE

P2860

Q34241307-039D44EB-F4B5-4C6E-9153-BE703FF4CF52

Q34241307-0F3F4BD0-E166-4AF4-A0C7-6BED0132B020

Q34241307-0FB0B2CF-F970-41E9-95D0-380BCFE3B3E6

Q34241307-144DC934-110C-451F-8D0B-AE5CAF7D5625

Q34241307-14CBC582-18E2-4D59-9356-BEE09F76E5F7

Q34241307-20BDA354-353C-4A91-AEF0-0A6CBDD13CC6

Q34241307-251BE788-6C5E-4ECE-8747-526DD269F7ED

Q34241307-27BC70C6-5035-4063-9CA7-5E59A05B4AEA

Q34241307-2CF15ECB-BC4F-49AA-9C36-3B5B45FAEE38

Q34241307-31781DB5-9F52-485B-8BED-E1CCCC8D433B

P304

Q34241307-826CC0D0-C12E-48E0-B6DB-309457C9E293

P31

Q34241307-456258D0-0B81-4780-ABA2-D255728CDDC4

P356

Q34241307-AE4E3045-60C0-4696-AD58-A19ADB4B8A05

P407

Q34241307-FD4D932A-AEA9-42BE-A291-67749410737C

P433

Q34241307-D0BD7BCE-3544-46DB-BD71-5519BC5E2917

P478

Q34241307-B62021AA-1BC1-4742-9D02-4ADF1E95F0F7

P50

Q34241307-E1083180-A7AD-4611-847E-CB7884A51F7E

P577

Q34241307-C60AF465-EBFC-41BB-ACB7-E319065E0336

P5875

Q34241307-4333AAC8-C007-4B79-BC99-0A0119FF165A

P698

Q34241307-3FF0E64C-6E24-4A47-AEFF-38D0E5471D5B

P921

Q34241307-04BB392B-D687-4D50-80DD-1717E452030A

P932

Q34241307-0DF21C14-E682-46FE-B4CC-B89083683D80

P356

PNAS.1006965107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Sildenafil increases chemother ...... eliorates cardiac dysfunction.

@en

P2093

Anindita Das

http://www.w3.org/2001/XMLSchema#string

Clint Mitchell

http://www.w3.org/2001/XMLSchema#string

David Durrant

http://www.w3.org/2001/XMLSchema#string

Eric Mayton

http://www.w3.org/2001/XMLSchema#string

Fadi N Salloum

http://www.w3.org/2001/XMLSchema#string

Ian Qureshi

http://www.w3.org/2001/XMLSchema#string

Margaret A Park

http://www.w3.org/2001/XMLSchema#string

Nicholas N Hoke

http://www.w3.org/2001/XMLSchema#string

Rakesh C Kukreja

http://www.w3.org/2001/XMLSchema#string

Ray Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Brick by brick: metabolism and tumor cell growth

Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

Mitochondrial control of cell death

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.

Adriamycin-induced heart failure: mechanism and modulation.

Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.

Liposomal anthracyclines in metastatic breast cancer: clinical update.

Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.

P304

18202-18207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1006965107

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47156525

http://www.w3.org/2001/XMLSchema#string

P698

20884855

http://www.w3.org/2001/XMLSchema#string

P921

P932

2964209

http://www.w3.org/2001/XMLSchema#string